cc VRE: a P4z| ream cols) Vol. 38, No. 12 Caan PERS PAS TAS BI ILEd Bie Sean eb HAITI «i MLS HAV AGATA CLeEN ALR Td e-mail : medtoday@medtoday.com.twPERKS BEST Bie UE ZR BER HAR GREP B38H B12 H040-044 HR eA 201112 A 15H RtRARE 940 EDS BEN TG Ee ORE ZERT EGEEREL RESRMEMEEA PE» BSA PRR GARRET ePIC + BK ‘SMR ERA - RANE BE ERE SP AA REF RE STR @ £SC86-FUb ARSE ES CERRHRNBAEERAN LE BRAKE AERHAB REARNE BRR: BR DRAM TARAS ASSET» ROREADFT + ABEL + (EBURE - SABIEATA + ER SER # ROAROFE BARHTRER F PEORARRVTE AMBLER HAR: MHLVASRACLERES BK SEAN SS FAH SE HOB i SRA AY BDRE AES A MRI - DEAS RRR EIT BE RRL» I REDE + rs ARR HAA + SPER «EO # FERRER SRAE > BSE TE Ala EU FS SARI BRRKREEM - BX FERRE AB EN AK » DA ERK Ns FRE eee EA Be SA MURR S CRM BSR SRNL FOREST + SBPASRBRER ALRBRM BEAR ELE SRE MATERA + REE PLS RCOENE RAI RIR + METRO RE aca" ETCSABRTRORGSRA {REVEAL > ERR F20~ 70% RA BT BIE °°? + 1977 + Hill et al ARBRE B BEA (RA + [AGT AR ee CE Drees eS EM BES? > Me Whirtert RSE» AL 40MM BEAR ZIG FERRE RE Ml HH ASE ERM SRR EE Ae + Ti BACB 23 ee HB a He SS eo - ESTER LESSEE CRP BP im » TEL Seer PE CE REAR Fite °° + Meguidte 1988: AVGT ALGER » FEE SOS RSE < 18.559 + EAE RE Re FHV A EIS Hn + EEE SRERE ? -BLBKEERA AA RESKAFSRKRHRM > SRF RA ‘PUES Ee Ss FUER RR > ML PEAMERE (gluta- nine) PENSE SS ARISES > Met HSARTEBRN EE RETO AS Kh PRR RES REBT BABE HWS B12 53 200 12A941 BRO + RARE SP STEPS TRARE AR 804% » (22909 TR ARENRE TASER at PSS BIAAS% ~ LOVER - 29h » Giner BeHuang A 7 EDL AOS A PL 1S BOA > RAO T HERR (masstricht index) A9SF(7HA » Ginerties Hin: SRA RRLEBI% » Huang FRB 100% > LTS + PRE RAR CABMENSRAKLA+ TES CREB PEK METAL ESAS FR EL» iri RUTH Be RE AR RIES ~ ABRRERATA ERABBER enteral nutrition) 24-9838 24 (parenteral nutrition) IA ARE - ERLE 1 RRUROEEES ASBMB ER PosK + AEA ae a a SH Fk: MELO - MME SOR RE SRBC RMT CHORE ABBE» RERBSA ~ UGE BONBAZINS » ERR EERAR WHETERSAR : HHO PLES ERIS + HIMRA BAMAKR (tube feeding) » "SEG RMAC HIT FE AE TADA RENE BA ZARA Sh MS RUE + PREPS» ARM Bia ° FDS R LAP MER LAGIE HOPSE PSEA AARET AE HERRERO ERR IEA (peripheral parenteral nutrition ; PPN) :28¥ AZ (total parenteral nutrition ; TPN) ma - HES BRS ERMREUOBR: BHR PREBLE RAS MA: Bee PICS + SC MR RE SE > ERD BR RATERAR LATE A SIMRO > SBR SEAR Et MERE RATE RNA WEEE REIMER RRNES | Bae ERR L BAREBONE RENE NEARER BH RRA RA HST RRR « REARS SMRFSMEMEAE (glutamine » GLA) » STL. ERE(ERMRSEEGS (heat shock protent,HSP ) 2 RA GE RN EME TSC I + HS RERMOMARK Mie RSTe HAUSA + TEETER BRERA + HBA Bir SAMMI > RARE (gultathione) SUSUEPRA "> SURE BRE ~ AEA OAS AS RTE AE RU ATAP IRE PRL » AR URARRAE AS AOORREE + OILLLFHMMIBE PAY RAMRRE RANE + BE SEMEL » SAMRAT HE FLED Re LR SRE ESI 70R {EBI20% > BAHU EB LETS HOREIEBI2I% » Fh AFAR AAS MMEEIZTM » PMS ALA ARMED SA BEB + KEE Sd FAR + GEST R RR RII FORT MERU A IRIE + SERRE BE FSA (SRK + SOKA + BRI BES PUES) > (AEE SEES PMBEKRA TER » Peau Ry F RAVER EE LAN IE» RRORKRERAES SESS EB SEZ ° BELO RS A /NEEMARP RARE RRNERSE Z — SOR RIE > SOK (bee - AB + Be RO ESTE AER R ORUCHRRIRESMRE > SORES ARO RT SHOE AL RAE AA) SUR ARE BUR > FMB a MSMATMAVHAA (intact proteins) + 5 BRGTAMNR ANCA TRI AN MRS B38 12H 54 201125sme URRIASHASS » BRIAR EMCEE RR AENTAERAME BRO RRA 1: WEG RERRN REY » BARA DPR KSPR REERIOR) ‘FERRE LHD EASA (peptide bound ) MTR KEPNRARS EAR SBM LMU RSM (polypeptides) A RULER + REKLAMA RAS ABA (complex proteins) » At AREY (82 COT ANRAKERECEAR PIERRE « PAAR AAAS» BE REGRESS ARM + ANT Fe IIE S AMR» BT BN F BABS Fe ESRRBESERK'” - ARBOReD SARA > GROMER. SASH + BE 2B + BRU Z te BAR TT LIER + 1995 4% > Krishnampprthy% A fa i} — Heat > “> ERE AN ERIE AY > SERRE GETS EY EY ER BT I A Be. VASA BeomUCRT DRC RARER + UR IRRA + SHARE ZR ROVE (Sietnesma et al.1993) > ERA AAR SHO ART SHER AY A Ge AE MG ZME (Grimble et al.1987) (> > FURR 159 77 eee EO RAMREV + SHB RCS AR #989 (Parrado et al,. 1991) © RUTTER» ERR» HE RERARARA TAN RTE CERBE RU LATA» (ARERR + ETE ‘MUAGMIRE TE (paracellular route) Ke MUBESE (transcellular route) » SRG RWR AA FREAK ERRERMMSORK: RAUENESA PEACE WEAK eT OS DB FHWA RO > “SIF A SHEN SMREROERAK BEM FET RUz + KrishnampprthyS As 942 oH > EAA HLF RE, (villi) SOA A, MRAM» AERTS AOU RR ARS? eR REABAL ASAPH R AGRE EAE RASTER II FAK» EERE Rani RAC « SMAMERE (glutamine) Al > BMRA BUA SBR (L-glutamine) HEKZL (glutamine peptide) » MAE FID TEMA PUPEAR GS SAMA (glutamine) > fee EP ROE + RE + BE EAE > EARLE RATA RB» 2001 Ap RrusHyWt Ge + MRAM AE De we Me Ee we WER ART (4000 T/A: 08R/A Ft) > RRS + AOR PAB ETEE » 1992 4F + Soubat FARRAR RR » SET PN A SI BE PO EK TSA ATP REMERON TEAR > TE DURA BneROR RS OT AVR MR NL eA FAA RA ARZERER > NB LE AER L Be 6H HD TR 7 AR RE, BS ok BE RK HKG - BER SRAM BPG EE > DUO MARRS] FA 2-6( REZ HER > TG EL ES 7 ame OO SE TE BR + AERA + [REAR AIRAR » RARE AR RUC NAA > ALARA TE SHAD AOR LEA RAS AS HEM (Eeickson,1955) “ » finde iB BEY REL EES EE TERE LHR SE FUMAG ES + EEDA RUBE SETA + Be SRA » BR RRRASEIARS » SeSOIG IRAE WCRUSERK ~ SHEA TE EAE + TMT KERAGMSSEER : S-RERRAT Rineee—te? - ANB BRU FER EE BEI Bk 1 3 FREER BE DSR » WE UL + RI RL ROARED ARS AEE IRE RMR ABA + EMU RE BREE BIS W12M 55 2104H125943 BRERHRAGAMT A GHIA Z PR EERE AAR (Sugiyama et al.1977 } Thompson and Debnam,1986) > RAMU OER ARGRRBY (Lis et aL1972) + TPEE/ BEREAN SAE L + 5 DAA MAOH + RSME IRAE FOVRERAIP GRL ( Lis et al.1972 + Fogel et al,1976) > SFRIMEAK IMAM Se Afe Lt RRS BA SSC Roee SRK + SI EA » FE PRRRRR NS ATMS > BR 2 FREI RE SBOE A HALTER (Lee,1955) & SPE MIGHT te th BAe A HAY BEE > TS» SARE ~ RUE AE + cA ROWE EFS SEE ere SABIE «NRE TAD ESA ZEA (tight junction) —fE SNP MRE RRS + LA ADEE + ROT RS ‘BURA > GAICHEL » BERLSILBE (V.cholerace ) #E4:89Zonula occludens toxin (Zot) RLATLABE ARM RE» AN BATIBIE » Zoi ABE RET SERGERIEAL » SH RRMEEIK REORMRAA IH (Fansano,1998) “+ SARK E RRR BORESOKAEM (Protease hydrolyzate ) & PEAT F BANE» SREGTSCAVERKARA EMO FACES SLR - MS + {G.F > SPUORREER + SCAT ~ BORE + PBR - ASAP RS RANE ACH» EPIRA RA Oy RO APART D EOAKMEP AMAR > LEER FSS FA EA RRR» KE FUCA SRA ~ MSR EI RHETT > LDR ~ (CABARET FA ISL RE MDE » SERRE BAKES ER ERR PE FF PRESALE PETES I(E RA» TEL ATURE EMARDL > SAREE + PETES MIIE TNR + ROKR = EG EK KOE OLA WROTE USE AE 4-FG SCARE KAM (Clemente and ‘Chambers,2000,Van Beresteijn et al.,1994) > /4F 2 ANE ERE BR * 1. eth: TAUNR ERASER Hy RPL ABA MOR BES AERESRARESMERRO RY RT SIMA M0: IS sich SSL > SURAE + POG AE + NTI ARRAS ARENA (Takamatsu et al., 2004) + (SURREAL » ATE + BE HAAR ARES) BUEN SOL PATER =e SB + OBL A EAM RABEL SRE AT » RLS (FDA) CAA ATER neem eee 4 > HAE ERRATA > ECAH etal, (1980) SREP ASA BURRS VEE ARE BESHRAAT CRORE PARED SCOT + RET RRR RETR LAT FRIPIBST LDA » TPCT » BIE AT RA SURS POEM AYRE FM AE BORAT RAM + ERT RIL Ih» PTR PACES sin StH% » Sugano and Koda (1993) #E%) > BR SPRELIRIBORR TB” PERM ERROR EAF A RR AL EM HE RTE RRA A (BCE) Feige CED) ASA Bute eee + 0 HET OO URS RTC hh > BS Be ea Bok es AL $@9KCCK (cholecystokinin ) #574) (Nishi et al, 2001) > HESS AE Ri EMA AYSUR + COCKS ATE » EPH LBB SLAB » ALPHA PAA ORE SRBE BIS B12 56 208125BL > SPATE » EE ABICCK BK A-FLCRF (lumenal cholecystokinin-releasing factor) FA RAF HRA ee Zt ROPE Re A fe ARIE + ET LORE BET RRO ) HETTMEIME IEE cn) * Nishi PRA UAB EBNRA RRS Z—P-conglycinin KMS, > SERRE RA Ma Oe BORGER + DREN TESA a « RDB ERBRKRM TER AAT si ED EE A #8) (angiotensin converting enzyme inhibitor. ACEI) SStHeittlit + sbRRS Ay2-14BE RK + TEL FY BATRA A-SI EPL RIED » BOR KMONRME MS eM BA BAERRMAHRACALAM mete BRE ARR MESRRZA BRERZSRESNRERSL MES - fh GRENSLRERERAARVAE BE ER LE BH EH EE + SRRMSRELEAG ERREROREL HANSEN BREAME HR EERER EAA OTR > ARERR PRU HT LL RE RSET RACY > REE RT CBRN - RTP Bb RHPA CAA ATH ETOP TB ESA AMIE * EA AGRE » ELTERE RL OYA SA TURE TENE ARAIES TE RESUS CHER: + RUD RERS + FEC + HE TURE BCOLORER + FEFHERACR - EY L.Edington J et al : Prevalence of malnutrition on admission to four hospitals in England. Clin Nutrition 19 : 191, 2000. 944 2.Kelly I E et al : Still hungry in hospital Identifying malnutrition in acute hospital admissions. QJ Med 93 : 93, 2000. 3.Kondrup Jet al : Incidence of nutritional risk and causes of inadequate nutritional care in hospitals. Clin Nutrition 21 + 461, 2002. 4.Wischmeyer PE : Glutamine:Mode of action in critical illness. Crit Care Med 35:S541,2007. SARS : SEE A 2 SEER OM BE 13 : 567, 2009 > OPES : EEE Ee - CAAE EBHERE SA SMA, 1996+ TPES | SEACH NMSA BES SE RTS EMS + Nutr Sci 31 + 95, 2006 = Smee: ABE REI - BROKERS 53 ¢ 37-41, 1994» OGRE + ES OER KARL Ea « FL BALA 33 + 58, 2001» 1LO.FMR + AAMT — BARRE + SETHE AHI 33: 15,2001 © LGR + AEDS MZ PRES» Ses API 31 : 40, 1999 12.9605: ARES IMERMMG ZH + HET 985 Fl 37 : 33,2005 - 13.PRIBE + ASE Pe Ee te Z fe tae fil » PUBOELE AT 33 : 23, 2000 - 14 AB GEE + RE + MRE RENT IA — SREREAAOME + RBS 61 + 362, 2008 « 15.002 + ERROR th] PIE ‘RELREM 236 : 90, 2010 + 16, SIRE + ERATURE » Sa IRA A 35 ¢ 38,2003 + 17. FRE + RUTH - MELLIA Fl 35 + 26, 2003 + 18.FT RGAE : SARGRE (Glutamine) ERASE LAE + GASES OAT 50, 2006 » MR BaeH 12H 67 2011128